Common stock only | |
S&P 500 only | |
Director Only | |
10% Owner Only |
Trans Codes
Select...
Amount
-
Trade FHTX Insider Trades:
all
Unusual
Whales
Unusual Whales
Unusual Whales
Powered by unusualwhales.com
Ticker
Trade Date
Filing Date
Name
Title
Code
Security
Amount
Price
Value
Trans.
Director
10% Owner
Mcap/AUM
2025-04-25
2025-04-28
GOTTSCHALK ADRIAN
Chief Executive Officer
G - Gift
Common Stock
-300K
$0.00
1
$230.77M
2025-04-25
2025-04-28
GOTTSCHALK ADRIAN
Chief Executive Officer
G - Gift
Common Stock
300K
$0.00
1
$230.77M
2025-04-09
2025-04-10
GOTTSCHALK ADRIAN
Chief Executive Officer
G - Gift
Common Stock
198K
$0.00
1
$230.77M
2025-04-09
2025-04-10
GOTTSCHALK ADRIAN
Chief Executive Officer
G - Gift
Common Stock
-198K
$0.00
1
$230.77M
2025-01-22
2025-01-24
RIVKIN ANNA
Chief Business Officer
A - Grant
Stock Option (right to buy)
50,000
$4.00
200K
1
$230.77M
2025-01-22
2025-01-24
COSTA CARLOS
Chief People Officer
A - Grant
Stock Option (right to buy)
115K
$4.00
460K
1
$230.77M
2025-01-22
2025-01-24
BELLON STEVEN
Chief Scientific Officer
A - Grant
Stock Option (right to buy)
140K
$4.00
560K
1
$230.77M
2025-01-22
2025-01-24
CARDAMA ALFONSO QUINTAS
Chief Medical Officer
A - Grant
Stock Option (right to buy)
125K
$4.00
500K
1
$230.77M
2025-01-22
2025-01-24
GOTTSCHALK ADRIAN
Chief Executive Officer
A - Grant
Stock Option (right to buy)
400K
$4.00
1.60M
1
$230.77M
2025-01-22
2025-01-24
HUMER KRISTIAN
Chief Financial Officer
A - Grant
Stock Option (right to buy)
120K
$4.00
480K
1
$230.77M
2025-01-22
2025-01-24
LACASCIA MICHAEL
Chief Legal Officer
A - Grant
Stock Option (right to buy)
126K
$4.00
504K
1
$230.77M
2024-09-23
2024-09-24
COSTA CARLOS
Chief People Officer
M - Exercise
Stock Option (right to buy)
-857
$0.00
1
$230.77M
2024-09-23
2024-09-24
COSTA CARLOS
Chief People Officer
S - Sale
Common Stock
-857
$10.00
-8,570
1
$230.77M
2024-09-23
2024-09-24
COSTA CARLOS
Chief People Officer
M - Exercise
Common Stock
857
$4.00
3,428
1
$230.77M
2024-09-20
2024-09-24
COSTA CARLOS
Chief People Officer
S - Sale
Common Stock
-35,756
$10.00
-358K
1
$230.77M
2024-09-20
2024-09-24
COSTA CARLOS
Chief People Officer
M - Exercise
Stock Option (right to buy)
-35,756
$0.00
1
$230.77M
2024-09-20
2024-09-24
COSTA CARLOS
Chief People Officer
M - Exercise
Common Stock
35,756
$4.00
143K
1
$230.77M
2024-09-18
2024-09-20
COSTA CARLOS
Chief People Officer
M - Exercise
Stock Option (right to buy)
-11,574
$0.00
1
$230.77M
2024-09-18
2024-09-20
COSTA CARLOS
Chief People Officer
M - Exercise
Common Stock
11,574
$4.00
46,296
1
$230.77M
2024-09-18
2024-09-20
COSTA CARLOS
Chief People Officer
S - Sale
Common Stock
-11,574
$10.00
-116K
1
$230.77M
2024-09-17
2024-09-18
COSTA CARLOS
Chief People Officer
M - Exercise
Stock Option (right to buy)
-10,272
$0.00
1
$230.77M
2024-09-17
2024-09-18
COSTA CARLOS
Chief People Officer
M - Exercise
Common Stock
10,272
$4.00
41,088
1
$230.77M
2024-09-17
2024-09-18
COSTA CARLOS
Chief People Officer
S - Sale
Common Stock
-10,272
$10.00
-103K
1
$230.77M
2024-09-16
2024-09-18
COSTA CARLOS
Chief People Officer
M - Exercise
Stock Option (right to buy)
-400
$0.00
1
$230.77M
2024-09-16
2024-09-18
COSTA CARLOS
Chief People Officer
M - Exercise
Common Stock
400
$4.00
1,600
1
$230.77M
2024-09-16
2024-09-18
COSTA CARLOS
Chief People Officer
S - Sale
Common Stock
-400
$10.00
-4,000
1
$230.77M
2024-09-09
2024-09-11
BELLON STEVEN
Chief Scientific Officer
S - Sale
Common Stock
-20,000
$10.00
-200K
1
$230.77M
2024-09-03
2024-09-04
RIVKIN ANNA
Chief Business Officer
A - Grant
Stock Options (Right to buy)
190K
$8.00
1.52M
1
$230.77M
2024-06-26
2024-06-28
LYNCH THOMAS JR.
A - Grant
Stock Options (Right to buy)
16,000
$6.00
96,000
1
$230.77M
2024-06-26
2024-06-28
MENDELSOHN MICHAEL
A - Grant
Stock Options (Right to buy)
16,000
$6.00
96,000
1
$230.77M
2024-06-26
2024-06-28
PARSHALL LYNNE
A - Grant
Stock Options (Right to buy)
16,000
$6.00
96,000
1
$230.77M
2024-05-22
2024-05-24
FLAGSHIP PIONEERING INC.
P - Purchase
Pre-Funded Warrants to purchase Common Stock
3.63M
$6.00
22M
2
$230.77M
2024-04-16
2024-04-17
HUMER KRISTIAN
Chief Financial Officer
A - Grant
Stock Option (Right to buy)
275K
$6.00
1.65M
1
$230.77M
2024-03-11
2024-03-12
CAVALIE FANNY
Chief Strategy/Bus Ops Officer
S - Sale
Common Stock
-11,000
$7.00
-77,000
1
$230.77M
2024-01-24
2024-01-25
BELLON STEVEN
Chief Scientific Officer
A - Grant
Stock Option (right to buy)
110K
$3.00
330K
1
$230.77M
2024-01-24
2024-01-25
CARDAMA ALFONSO QUINTAS
Chief Medical Officer
A - Grant
Stock Option (right to buy)
60,000
$3.00
180K
1
$230.77M
2024-01-24
2024-01-25
CAVALIE FANNY
Chief Strategy/Bus Ops Officer
A - Grant
Stock Option (right to buy)
80,000
$3.00
240K
1
$230.77M
2024-01-24
2024-01-25
COSTA CARLOS
Chief People Officer
A - Grant
Stock Option (right to buy)
90,000
$3.00
270K
1
$230.77M
2024-01-24
2024-01-25
GOTTSCHALK ADRIAN
Chief Executive Officer
A - Grant
Stock Option (right to buy)
300K
$3.00
900K
1
$230.77M
2024-01-24
2024-01-25
LACASCIA MICHAEL
Chief Legal Officer
A - Grant
Stock Option (right to buy)
100K
$3.00
300K
1
$230.77M
2023-09-11
2023-09-13
CARDAMA ALFONSO QUINTAS
Chief Medical Officer
A - Grant
Stock Options (Right to buy)
272K
$8.00
2.18M
1
$230.77M
2023-08-17
2023-08-18
GOTTSCHALK ADRIAN
Chief Executive Officer
G - Gift
Common Stock
-63,000
$0.00
1
$230.77M
2023-08-17
2023-08-18
GOTTSCHALK ADRIAN
Chief Executive Officer
G - Gift
Common Stock
63,000
$0.00
1
$230.77M
2023-08-16
2023-08-18
AGRESTA SAMUEL
Chief Medical Officer
S - Sale
Common Stock
-311K
$8.00
-2.49M
1
$230.77M
2023-08-16
2023-08-18
AGRESTA SAMUEL
Chief Medical Officer
M - Exercise
Stock Option (right to buy)
-311K
$0.00
1
$230.77M
2023-08-16
2023-08-18
AGRESTA SAMUEL
Chief Medical Officer
M - Exercise
Common Stock
311K
$4.00
1.25M
1
$230.77M
2023-05-26
2023-05-31
GOTTSCHALK ADRIAN
Chief Executive Officer
G - Gift
Common Stock
300K
$0.00
1
$230.77M
2023-05-26
2023-05-31
GOTTSCHALK ADRIAN
Chief Executive Officer
G - Gift
Common Stock
-300K
$0.00
1
$230.77M
2023-02-17
2023-02-22
GOTTSCHALK ADRIAN
Chief Executive Officer
J - Other
Common Stock
-185K
$0.00
1
$230.77M
2023-02-17
2023-02-22
GOTTSCHALK ADRIAN
Chief Executive Officer
J - Other
Common Stock
185K
$0.00
1
$230.77M
2023-02-17
2023-02-22
GOTTSCHALK ADRIAN
Chief Executive Officer
G - Gift
Common Stock
-4,371
$0.00
1
$230.77M
2023-02-17
2023-02-22
GOTTSCHALK ADRIAN
Chief Executive Officer
G - Gift
Common Stock
4,371
$0.00
1
$230.77M
2022-10-25
2023-02-22
GOTTSCHALK ADRIAN
Chief Executive Officer
J - Other
Common Stock
-4,371
$0.00
1
$230.77M
2022-10-25
2023-02-22
GOTTSCHALK ADRIAN
Chief Executive Officer
J - Other
Common Stock
4,371
$0.00
1
$230.77M
2022-02-10
2023-02-22
GOTTSCHALK ADRIAN
Chief Executive Officer
G - Gift
Common Stock
-123K
$0.00
1
$230.77M
2022-02-10
2023-02-22
GOTTSCHALK ADRIAN
Chief Executive Officer
G - Gift
Common Stock
123K
$0.00
1
$230.77M
2023-01-26
2023-01-30
BELLON STEVEN
Chief Scientific Officer
A - Grant
Stock Option (right to buy)
100K
$0.00
1
$230.77M
2023-01-26
2023-01-30
CAVALIE FANNY
Chief Strategy/Bus Ops Officer
A - Grant
Stock Option (right to buy)
65,000
$0.00
1
$230.77M
2023-01-26
2023-01-30
COSTA CARLOS
Chief People Officer
A - Grant
Stock Option (right to buy)
65,000
$0.00
1
$230.77M
2023-01-26
2023-01-30
LACASCIA MICHAEL
Chief Legal Officer
A - Grant
Stock Option (right to buy)
90,000
$0.00
1
$230.77M
2023-01-26
2023-01-30
REINE ALLAN
Chief Financial Officer
A - Grant
Stock Option (right to buy)
90,000
$0.00
1
$230.77M
2023-01-26
2023-01-30
GOTTSCHALK ADRIAN
Chief Executive Officer
A - Grant
Stock Option (right to buy)
280K
$0.00
1
$230.77M
2023-01-26
2023-01-30
AGRESTA SAMUEL
Chief Medical Officer
A - Grant
Stock Option (right to buy)
60,000
$0.00
1
$230.77M
2022-10-27
2022-10-31
LYNCH THOMAS JR.
A - Grant
Stock Options (Right to buy)
32,000
$8.00
256K
1
$230.77M
2022-09-16
2022-09-19
GOTTSCHALK ADRIAN
Chief Executive Officer
M - Exercise
Stock Option (right to buy)
-40,000
$0.00
1
$230.77M
2022-09-16
2022-09-19
GOTTSCHALK ADRIAN
Chief Executive Officer
M - Exercise
Common Stock
40,000
$1.00
40,000
1
$230.77M
2022-08-16
2022-08-18
PARSHALL LYNNE
A - Grant
Stock Options (Right to buy)
32,000
$16.00
512K
1
$230.77M
2022-08-11
2022-08-15
BELLON STEVEN
Chief Scientific Officer
M - Exercise
Stock Options (Right to buy)
-1,858
$0.00
1
$230.77M
2022-08-11
2022-08-15
BELLON STEVEN
Chief Scientific Officer
M - Exercise
Common Stock
1,858
$4.00
7,432
1
$230.77M
2022-08-01
2022-08-03
COSTA CARLOS
Chief People Officer
A - Grant
Stock Option (right to buy)
50,000
$0.00
1
$230.77M
2022-05-25
2022-05-27
BELLON STEVEN
Chief Scientific Officer
M - Exercise
Stock Options (Right to buy)
-4,392
$0.00
2
$230.77M
2022-05-25
2022-05-27
BELLON STEVEN
Chief Scientific Officer
M - Exercise
Common Stock
4,392
$3.00
13,176
2
$230.77M
2022-01-26
2022-01-28
REINE ALLAN
Chief Financial Officer
A - Grant
Stock Option (right to buy)
135K
$0.00
1
$230.77M
2022-01-26
2022-01-28
AGRESTA SAMUEL
Chief Medical Officer
A - Grant
Stock Option (right to buy)
125K
$0.00
1
$230.77M
2022-01-26
2022-01-28
BELLON STEVEN
Chief Scientific Officer
A - Grant
Stock Option (right to buy)
150K
$0.00
1
$230.77M
2022-01-26
2022-01-28
GOTTSCHALK ADRIAN
Chief Executive Officer
A - Grant
Stock Option (right to buy)
440K
$0.00
1
$230.77M
2022-01-26
2022-01-28
LACASCIA MICHAEL
Chief Legal Officer
A - Grant
Stock Option (right to buy)
135K
$0.00
1
$230.77M
2021-12-09
2021-12-13
DECICCO CARL
Chief Scientific Officer
M - Exercise
Stock Options (Right to buy)
-104K
$0.00
2
$230.77M
2021-12-09
2021-12-13
DECICCO CARL
Chief Scientific Officer
M - Exercise
Common Stock
104K
$4.00
417K
1
$230.77M
2021-08-20
2021-08-23
GOTTSCHALK ADRIAN
Chief Executive Officer
M - Exercise
Stock Options (Right to buy)
-23,000
$0.00
1
$230.77M
2021-08-20
2021-08-23
GOTTSCHALK ADRIAN
Chief Executive Officer
M - Exercise
Common Stock
23,000
$1.00
23,000
1
$230.77M
2021-08-09
2021-08-11
REINE ALLAN
Chief Financial Officer
M - Exercise
Stock Options (Right to buy)
26,892
$0.00
1
$230.77M
2021-08-09
2021-08-11
REINE ALLAN
Chief Financial Officer
M - Exercise
Common Stock
26,892
$4.00
108K
1
$230.77M
2021-01-28
2021-02-01
AGRESTA SAMUEL
Chief Medical Officer
A - Grant
Stock Option (Right to Buy)
100K
$0.00
1
$230.77M
2021-01-28
2021-02-01
DECICCO CARL
Chief Scientific Officer
A - Grant
Stock Option (Right to Buy)
100K
$0.00
1
$230.77M
2021-01-28
2021-02-01
GOTTSCHALK ADRIAN
President & Chief Executive Of...
A - Grant
Stock Option (Right to Buy)
300K
$0.00
1
$230.77M
2021-01-28
2021-02-01
REINE ALLAN
Chief Financial Officer
A - Grant
Stock Option (Right to Buy)
120K
$0.00
1
$230.77M
2020-11-17
2020-11-18
LACASCIA MICHAEL
Chief Legal Officer
A - Grant
Stock Option (Right to Buy)
162K
$0.00
1
$230.77M
2020-10-27
2020-10-29
FLAGSHIP VENTURES FUND GENERAL PARTNER LLC
C - Conversion
Series A-1 Convertible Preferred Stock
-7.50M
1
$230.77M
2020-10-27
2020-10-29
FLAGSHIP VENTURES FUND GENERAL PARTNER LLC
C - Conversion
Series A-2 Convertible Preferred Stock
-8.33M
1
$230.77M
2020-10-27
2020-10-29
FLAGSHIP VENTURES FUND GENERAL PARTNER LLC
C - Conversion
Series B Convertible Preferred Stock
-7.34M
3
$230.77M
2020-10-27
2020-10-29
FLAGSHIP VENTURES FUND GENERAL PARTNER LLC
C - Conversion
Common Stock
13M
5
$230.77M
2020-10-27
2020-10-29
GOTTSCHALK ADRIAN
President & Chief Executive Of...
C - Conversion
Series A-2 Convertible Preferred Stock
-18,018
1
$230.77M
2020-10-27
2020-10-29
GOTTSCHALK ADRIAN
President & Chief Executive Of...
C - Conversion
Series B Convertible Preferred Stock
-7,207
1
$230.77M
2020-10-27
2020-10-29
GOTTSCHALK ADRIAN
President & Chief Executive Of...
C - Conversion
Common Stock
25,225
1
$230.77M
2020-10-27
2020-10-29
DECICCO CARL
Chief Scientific Officer
P - Purchase
Common Stock
5,500
$16.00
88,000
1
$230.77M
2020-10-27
2020-10-29
FLAGSHIP VENTURES FUND GENERAL PARTNER LLC
P - Purchase
Common Stock
150K
$16.00
2.40M
3
$230.77M
2020-10-27
2020-10-28
ABU DHABI INVESTMENT AUTHORITY
C - Conversion
Series B Preferred Stock
-2.00M
1
$230.77M
2020-10-27
2020-10-28
ABU DHABI INVESTMENT AUTHORITY
P - Purchase
Common Stock
150K
$16.00
2.40M
1
$230.77M